1.6K
Articles
47.8K
Citations
3.2
avg. Impact Factor
92
h-index

Most Cited Articles of Department of Oncology in 2014

TitleJournalYearCitations
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective studyHepatology2014196
Autophagy promotes resistance to photodynamic therapy-induced apoptosis selectively in colorectal cancer stem-like cellsAutophagy2014129
Gallic acid ameliorated impaired glucose and lipid homeostasis in high fat diet-induced NAFLD micePLoS ONE2014114
Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunityInternational Journal of Cancer201487
An open-label, single-arm, phase 2 trial of the Polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancerCancer201469
Clinical and the prognostic characteristics of lung adenocarcinoma patients with ROS1 fusion in comparison with other driver mutations in East Asian populationsJournal of Thoracic Oncology201457
A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignanciesBritish Journal of Cancer201456
A prospective, claims-based assessment of the risk of pancreatitis and pancreatic cancer with liraglutide compared to other antidiabetic drugsDiabetes, Obesity and Metabolism201456
Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesisModern Pathology201455
Re-evaluating transarterial chemoembolization for the treatment of hepatocellular carcinoma: Consensus recommendations and review by an International Expert PanelLiver International201453
Treatment of advanced non-small-cell lung cancer with epidermal growth factor receptor (EGFR) mutation or ALK gene rearrangement: results of an international expert panel meeting of the Italian Association of Thoracic OncologyClinical Lung Cancer201450
Definition of PKC-α, CDK6, and MET as therapeutic targets in triple-negative breast cancerCancer Research201448
Recent advances in the prevention of hepatocellular carcinoma recurrenceSeminars in Liver Disease201443
H3K9 histone methyltransferase, KMT1E/SETDB1, cooperates with the SMAD2/3 pathway to suppress lung cancer metastasisCancer Research201443
Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapyActa Obstetricia Et Gynecologica Scandinavica201442
Osteoblast-derived WNT-induced secreted protein 1 increases VCAM-1 expression and enhances prostate cancer metastasis by down-regulating miR-126Oncotarget201442
Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancerJournal of Thoracic Oncology201441
Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stressOncotarget201441
Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapyJournal of Hepatology201436
Epidermal growth factor receptor mutation analysis in previously unanalyzed histology samples and cytology samples from the phase III Iressa Pan-ASia Study (IPASS)Lung Cancer201436
Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancerJournal of Thoracic Oncology201435
Targeting Phosphatidylinositide3-Kinase/Akt pathway by BKM120 for radiosensitization in hepatocellular carcinomaOncotarget201434
Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an East Asian country: a nationwide cancer registry-based studyOncologist201429
Lumbosacral spine and marrow cavity modeling of acute hematologic toxicity in patients treated with intensity modulated radiation therapy for squamous cell carcinoma of the anal canalPractical Radiation Oncology201428
Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivinMolecular Cancer201428